Your browser doesn't support javascript.
loading
The nuclear factor E2-related factor 2 and age-related macular degeneration.
Torres, Rogil José de Almeida; Torres, Rogério João de Almeida; Luchini, Andréa; Ferreira, Ana Lúcia Dos Anjos.
Affiliation
  • Torres RJA; Universidade Estadual Paulista "Júlio de Mesquita Filho", Botucatu, SP, Brazil.
  • Torres RJA; Departamento de Oftalmologia, Hospital Angelina Caron, Campina Grande do Sul, PR, Brazil.
  • Luchini A; Centro Oftalmológico de Curitiba, Curitiba, PR, Brazil.
  • Ferreira ALDA; Universidade Estadual Paulista "Júlio de Mesquita Filho", Botucatu, SP, Brazil.
Arq Bras Oftalmol ; 86(2): 178-187, 2023.
Article in En | MEDLINE | ID: mdl-35417516
After the discovery of anti-vascular endothelial growth factor agents as treatment of wet age-related macular degeneration, the number of studies with the objective to understand the molecular mechanisms involved in the age-re lated macular degeneration genesis has increased. The importance of the nuclear factor e2-related factor 2 lies in its activation-derived proteins being involved in the maintenance of the redox balance and consequent prevention of degenerative macular disease. This article aims to present the characteristics of nuclear factor e2-related factor 2 and describe the main nuclear factor e2-related factor 2-activated antioxidant enzymes that contribute to the preservation of vision.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Angiogenesis Inhibitors / Wet Macular Degeneration Limits: Humans Language: En Journal: Arq Bras Oftalmol Year: 2023 Document type: Article Affiliation country: Brazil Country of publication: Brazil

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Angiogenesis Inhibitors / Wet Macular Degeneration Limits: Humans Language: En Journal: Arq Bras Oftalmol Year: 2023 Document type: Article Affiliation country: Brazil Country of publication: Brazil